RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls
Nephrology Dialysis Transplantation · 31.07.2026 · 41 (8) · 1436-1447
DOI: 10.1093/ndt/gfag002 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 13.01.2026. Verfasst von Hector Rincon-Arevalo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, Renal Dialysis, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: DFG, Else Kröner Fresenius Stiftung, COLCIENCIAS.
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) causes severe respiratory illness in vulnerable populations, including kidney transplant recipients (KTRs) and dialysis patients (DPs). Despite the availability of RSV prefusion F protein–based vaccines, immune phenotyping of vaccine-specific B and T cells in KTRs and DPs remains limited. We hypothesized that RSVPreF3OA vaccination induces distinct immune signatures in KTRs and DPs compared with healthy controls (HCs), reflecting the impact of immunosuppression and uraemia on vaccine-induced B and T cell responses.
Methods
In this observational cohort, we analysed humoral and cellular responses following routine vaccination with the adjuvanted prefusion F protein–based RSVPreF3OA vaccine in 23 KTRs, 14 DPs and 24 HCs. Blood and saliva were collected at baseline and on days 30 and 90 post-vaccination. RSV-specific serum immunoglobulin G/immunoglobulin A, salivary antibodies and antigen-specific B and T cells were quantified by enzyme-linked immunosorbent assay and spectral flow cytometry, with tetanus- and severe acute respiratory syndrome coronavirus 2–specific responses assessed in parallel.
Results
In KTRs, vaccination induced increases in serum and salivary antibodies, expansion of RSV-specific B cells with enrichment of a switched memory phenotype unique to RSV-specific B cells and induction of RSV-A– and RSV-B–specific T cells with effector cytokine production. These signatures resembled those observed in HCs, whereas responses in DPs were delayed and attenuated. Across cohorts, RSV-specific B and T cells showed comparable phenotypic and functional characteristics.
Conclusions
This study provides detailed immunophenotyping of RSVPreF3OA vaccine responses in KTRs, DPs and HCs over 90 days, showing that RSVPreF3OA vaccination induces protective RSV responses among KTRs comparable to HCs while DPs mount modestly lower cellular and humoral responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Deutsches Rheuma-Forschungszentrum, an Institute of the Leibniz Association, Berlin, Germany.
- Grupo de Inmunología Celular e Inmunogenética, Facultad de Medicina, Instituto de Investigaciones Médicas, Universidad de Antioquia, Medellín, Colombia.
- Kuratorium for Dialysis and Transplantation Renal Unit Berlin-Mitte, Berlin, Germany.
ORCID-Profile: Hector Rincon-Arevalo, Jacob Ritter, Kai-Uwe Eckardt, Klemens Budde
Förderung
- DFG
- Else Kröner Fresenius Stiftung
- COLCIENCIAS
- Jürgen Manchot Foundation
- BMBF
- Clinical Research Unit
- Leibniz Association
Zitieren
APA
Rincon-Arevalo, H., Halleck, F., Böger, D., Rosenlehner, E., Stefanski, A. L., Carli, C., Avaniadi, P. D., Bachmann, F., Dreveton, L. S., Henning, A., Ritter, J., Wiedemann, A., Staeck, O., Eckardt, K. U., Khadzhynov, D., Budde, K., Kruglov, A., Dörner, T., & Schrezenmeier, E. (2026). RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls. Nephrology Dialysis Transplantation, 41(8), 1436-1447. https://doi.org/10.1093/ndt/gfag002
Vancouver
Rincon-Arevalo H, Halleck F, Böger D, Rosenlehner E, Stefanski AL, Carli C, et al. RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls. Nephrology Dialysis Transplantation. 2026;41(8):1436-1447. doi:10.1093/ndt/gfag002
BibTeX
@article{RinconArevalo2026,
author = {Rincon-Arevalo, Hector and Halleck, Fabian and Böger, Dorottya and Rosenlehner, Elias and Stefanski, Ana-Luisa and Carli, Caterina and Avaniadi, Parthenopi Despina and Bachmann, Friederike and Dreveton, Léa-Sophie and Henning, Anna and Ritter, Jacob and Wiedemann, Annika and Staeck, Oliver and Eckardt, Kai-Uwe and Khadzhynov, Dmytro and Budde, Klemens and Kruglov, Andrey and Dörner, Thomas and Schrezenmeier, Eva},
title = {RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
volume = {41},
number = {8},
pages = {1436--1447},
doi = {10.1093/ndt/gfag002}
}
EUVIMED